Ignite Planners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
6,265
-398
-6% -$92.7K 0.24% 106
2025
Q4
$1.51M Buy
6,663
+114
+2% +$22.5K 0.23% 101
2025
Q3
$1.21M Buy
6,549
+126
+2% +$21.6K 0.2% 118
2025
Q2
$1.05M Sell
6,423
-30
-0.5% -$4.61K 0.18% 127
2025
Q1
$997K Buy
6,453
+776
+14% +$121K 0.2% 121
2024
Q4
$819K Sell
5,677
-7
-0.1% -$1.08K 0.18% 118
2024
Q3
$921K Buy
5,684
+26
+0.5% +$4.14K 0.21% 100
2024
Q2
$829K Buy
5,658
+76
+1% +$11.3K 0.2% 103
2024
Q1
$881K Sell
5,582
-963
-15% -$153K 0.25% 91
2023
Q4
$1.05M Sell
6,545
-1,568
-19% -$240K 0.31% 84
2023
Q3
$1.28M Buy
8,113
+214
+3% +$35.3K 0.39% 66
2023
Q2
$1.26M Buy
7,899
+876
+12% +$141K 0.48% 47
2023
Q1
$1.15M Buy
7,023
+753
+12% +$122K 0.47% 56
2022
Q4
$1.06M Buy
6,270
+1,193
+23% +$206K 0.44% 61
2022
Q3
$829K Buy
5,077
+857
+20% +$145K 0.66% 41
2022
Q2
$753K Buy
4,220
+164
+4% +$29.2K 0.62% 45
2022
Q1
$735K Buy
4,056
+252
+7% +$42.9K 0.49% 55
2021
Q4
$636K Buy
+3,804
New +$623K 0.41% 73

Other funds holding JNJ

Ignite Planners's JNJ Position: Q1 2026 in Review

Ignite Planners reduced its Johnson & Johnson (JNJ) stake by 6% in Q1 2026, selling an estimated $92.7K and leaving 6,265 shares worth $1.53M. The position accounts for 0.24% of the portfolio, ranked #106.

Ignite Planners first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ignite Planners held 6,265 shares of Johnson & Johnson worth $1.53M as of Q1 2026.
  • Ignite Planners sold 398 Johnson & Johnson shares in Q1 2026, an estimated $92.7K.
  • Johnson & Johnson made up 0.24% of Ignite Planners's portfolio in Q1 2026, its #106 holding.
  • Ignite Planners first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ignite Planners's 13F filing for Q1 2026, filed 17 Apr 2026.